Healthcare Chatbots Market Analysis

Global Healthcare Chatbots Market Overview

Healthcare Chatbots Market Size was valued at USD 0.2 billion in 2022. The healthcare chatbots market industry is projected to grow from USD 0.24 Billion in 2023 to USD 0.99 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.5% during the forecast period (2023 - 2032).

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Medtronic (Ireland) and DaVita Inc. (U.S.) are collaborating to establish a new independent medical device company focused on kidney care (“NewCo” or “the Company”). The company aims to improve patient treatments and overall outcomes.

Ethicon, Inc. (U.S.) (J&J), in April 2022, announced the launch of an electrosurgical generator for use in wide open and laparoscopic procedures. It is a microprocessor-controlled, isolated output, high-frequency generator capable of enabling both monopolar cutting and coagulation as well as bipolar coagulation through an accessory electrode.

Sensely Labs disclosed in April 2023 that its front door navigator product initially introduced ChatGPT. By Front Door Navigator, policyholders under insurance can readily get intuitive answers to their most crucial questions.

WhatsApp’s new health education chatbot for young women in India called ‘Bol Behen’ or Speak Sister, has been launched this month with help from the non-profit Girl Effect. This tool was unveiled with the aim of supporting adolescent girls and women who have concerns about their general health and sexual well-being.

Genie from Ivy.ai is a self-building chatbot platform that allows businesses to quickly build conversational chatbots that can identify specific content.

WhatsApp has introduced an AI-powered health education chatbot designed just for young Indian females in partnership with not-for-profit Girl Effect called ‘Bol Behen’, which means speak sister’. This initiative came up to help teenagers as well as ladies who might be having some queries regarding their general well-being, including sexual wellness.

March 2022 – Ivy.ai has rolled out Genie, which is a self-building technology for chatbots, enabling fast development of pre-trained conversational bots that are able to recognize specific entities.

This June, Ada Health GmbH unveiled significant enhancements to its AI-driven chatbot. The expansion of the medical database by the company enhanced the accuracy of symptom assessment and health recommendations. Additionally, in August 2023, it started integrating its chatbot into telemedicine platforms and electronic health record systems by partnering with healthcare providers and organizations.

In April 2023, Babylon Inc. actively progressed its telehealth platform. The introduction of virtual consultations with doctors through their chatbot enabled patients to get medical advice as well as prescriptions. Moreover, the firm worked on language support for the chatbot in July 2023 to include a broader patient demographic.

Buoy Health Inc. announced this September that it would enhance its symptom assessment chatbot. It used sophisticated machine learning algorithms to improve diagnosis accuracy. Furthermore, Buoy Health announced collaborations with health insurers that would enable their chatbot to guide users toward appropriate healthcare coverage options.

In March 2024, Quickblox, a prominent provider of communication platforms powered by artificial intelligence, introduces its HIPAA-compliant chatbot, which has been approved by OpenAI. This chatbot is designed to enhance communication in the healthcare business while ensuring the highest level of safety and compliance with HIPAA regulations. Quickblox is delighted to be among the first to receive OpenAI's HIPAA-compliant chatbot Business Associate Agreement (BAA). 

This milestone allows us to further in our mission of offering secure communication channels for patients and healthcare professionals. Quickblox offers comprehensive software development kits (SDKs), application programming interfaces (APIs), and a teleconsultation application that can assist hospitals in creating telehealth platforms that comply with the Health Insurance Portability and Accountability Act (HIPAA). 

These platforms can optimize hospital operations, minimize waiting times, and enhance the flexibility of existing virtual healthcare services. By utilizing cutting-edge AI technology, the HIPAA-compliant "SmartChat Assistant" facilitates smooth communication while strictly complying to HIPAA laws, ensuring the protection of sensitive patient information. OpenAI's BAA guarantees that any input utilized by the tool to generate responses, including patient requests and medical information, cannot be stored by the third party, ensuring complete confidentiality.

In October 2023, Mendel.ai, a startup utilizing artificial intelligence, unveiled Hypercube, an advanced platform that combines organized and unorganized medical information. This platform democratizes analytics and enables users to ask questions in natural language and obtain results based on specific patient data.  

BeMe Health, a platform focused on the mental health of teenagers, has announced that Blue Cross of Kansas has become a new strategic investor in the firm. Additionally, BeMe Health has launched a new service that allows teenagers to interact with their community network.

Healthcare Chatbots Market Trends

• Growing internet connectivity and smart device adoption to boost market growth

A significant aspect driving the growth of the healthcare chatbots market is the rise in hospital cost savings based on by the use of healthcare chatbots globally. Another factor that supports the market's expansion is the rise in internet connectivity and the use of smart devices. Additionally, the market for healthcare chatbots is growing due to an increase in patient wait times and a lack of effective patient management globally. Additionally, during the projection period, the market would have lucrative growth prospects due to the growth potential offered by the increase in awareness.

A major factor in ensuring the acceptance and use of chatbots is the increase in Internet connectivity as well as the increasing use of smartphones and mobile platforms. Due to this, a greater number of people may now receive healthcare services, significantly expanding their reach. The majority of smartphone users (52%), 36% of doctors (who feel apps are the most effective way to communicate with patients), and 93% of doctors believe mobile applications can enhance health, according to statistics provided by Anthem Insurance Companies, Inc. (US) in May 2017. 

Advanced chatbot technologies on smart devices solve a number of important communication problems in the healthcare industry. Therefore, a rise in smartphone and device penetration would help the worldwide market CAGR of healthcare chatbots.

Moreover, chatbots are a wonderful fit for patient engagement due to significant advancements in artificial intelligence (AI) and natural language processing (NLP). The foundation for healthcare chatbots has significantly improved over the past few years so they can identify the actual symptoms and signals of various diseases or diseases. These elements support the expansion of international chatbots in the healthcare sector. Furthermore, a significant factor fueling the expansion of the market is the interest the general public worldwide is exhibiting in healthcare mobile applications. The use of mobile applications to interact with patients is becoming more and more popular among healthcare providers. 

Mobile applications have gained huge popularity as they have obtained the nod from doctors and hospitals who are able to recognize the potential of chatbots in healthcare and are promoting such applications for the control of multiple medical conditions. However, concerns about data privacy and a lack of knowledge regarding chatbot development may limit the target market's growth during the anticipated term. However, chatbots that are focused on social media platforms and cloud-based models are generating prosperous expansion chances for the healthcare chatbots market revenue.

Healthcare Chatbots Market Segment Insights

Healthcare Chatbots Component Insights

The market segments of healthcare chatbots, based on Component, includes Software, Services. The Software healthcare chatbots segment held the majority share in 2022. This is primarily owing to the raising understanding of self-monitoring techniques in diagnosis and management, as well as the increase in smartphone usage, are cruising the growth of the chatbots software sector.

For instance, in May 2021, Sapio Smart Healthcare, a subsidiary of Indian government recognises Sapio Analytics, has established a chatbot that helps patients from remote and rural areas in India. According to a news release, the AKS Sapio Med Bot was developed to assist patients find treatment before seeking medical consultations by understanding their "local and particular" concerns.

Healthcare Chatbots Deployment Type Insights

The healthcare chatbots market segmentation, based on Deployment type, includes On-premise, Cloud-based. The Cloud-based segment dominated the market in 2022 and also projected to be the faster-growing segment during the forecast period, 2023-2032. This is due to the numerous benefits that these chatbots provide. For instance, compared to on-premise chatbots, cloud-based chatbots are more accessible, need less initial investment, and may be modified less. As a result, the aforementioned reasons support the market expansion for healthcare chatbots. Hence, rising deployment type for healthcare chatbots positively impacts the market growth.

Healthcare Chatbots Application Insights

The healthcare chatbots market data has been bifurcated by application into Symptom Checking & Medication assistance, Appointment scheduling & medical guidance. The Symptom Checking & Medication assistance segment dominated the market in 2022. owing to the increase internet usage and rise in the level of medical available information at patient level. Furthermore, due to the need to minimize patient wait times and make effective use of healthcare resources, appointment scheduling & medical guidance is anticipated to experience the fastest growth during the projection period.

Figure 2: Healthcare Chatbots Market, by Application, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Healthcare Chatbots Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Healthcare Chatbots market accounted for USD 0.092 billion in 2022 and is expected to exhibit a significant CAGR 45.80% growth during the study period. This is attributed to increasing use of smart devices, a rise in the number of treatment chatbots, and an increase in venture capital funding for the creation of cutting-edge chatbots. Additionally, the high patient long waits support the expansion of the North American market for healthcare chatbots.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: Healthcare Chatbots Market Share By Region 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe healthcare chatbots market accounts for the second-largest market share due to the service's easy availability for healthcare chatbots. Additionally, the high patient long waits support the expansion of the Europe market for healthcare chatbots. Further, the Germany market of healthcare chatbots held the largest market share, and the United Kingdom market of healthcare chatbots was the fastest growing market in the European region

The Asia-Pacific Healthcare Chatbots Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to an increase in public awareness of the use of healthcare chatbots. Market expansion in developing nations like Malaysia, China, and others is fueled by the life science sector, which is continually evolving. Moreover, China market of healthcare chatbots held the largest market share, and the India market of healthcare chatbots was the fastest growing market in the Asia-Pacific region

Healthcare Chatbots Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of healthcare chatbots grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the healthcare chatbots industry must offer cost-effective products and services to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the healthcare chatbots industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, healthcare chatbots industry has provided transparency and reduced disruptions in supply chain. The healthcare chatbots market major player such as Sensely Inc. (U.S.), MD (U.K.), Buoy Health Inc. (U.S.), Infermedica (Poland), PACT Care BV (The Netherlands), HealthTap Inc. (U.S.), Babylon Health (U.K.), Ada Health GmbH (Germany), Woebot Labs Inc. (U.S.), COM Inc. (U.S.) and others are working to expand the market demand by investing in research and development activities.

A company named HealthTap builds an online telemedicine platform that gives patients immediate access to doctors for all-encompassing care. Gyant, a firm that specialises in the patient journey, announced in June 2020 that Intermountain Healthcare has joined forces with it to introduce its ASYNC asynchronous e-Visit care platform.

Also, Woebot Health was established in 2017 and its headquarters is in San Francisco, CA. The first mental health ally in the world for individuals and organisations, Woebot Health offers scalable, profoundly engaging AI-powered therapy solutions for mental health. Woebot Health has developed into an emerging force of change in mental health from a little tech experiment relieving anxiety in teenagers. For instance, Woobot, that was launched for iOS in January 2018 on the Apple iTunes Store, is the only mental health chatbot with scientific evidence that it can lessen the symptoms of mood-based disorders.

Key Companies in the market of healthcare chatbots includes

• Sensely Inc. (U.S.)


• MD (U.K.)


• Buoy Health Inc. (U.S.)


• Infermedica (Poland)


• PACT Care BV (The Netherlands)


• HealthTap Inc. (U.S.)


• Babylon Health (U.K.)


• Ada Health GmbH (Germany)


• Woebot Labs Inc. (U.S.)


• COM Inc. (U.S.), among others

Healthcare Chatbots Industry Developments

March 2022: Genie, a self-building chatbot platform from Ivy.ai, enables companies to swiftly create conversational chatbots that can identify varying results.

Healthcare Chatbots Market Segmentation

Healthcare Chatbots Component Outlook

• Software


• Services

Healthcare Chatbots Deployment type Outlook

• On-premise


• Cloud-based

Healthcare Chatbots Application Outlook

• Symptom Checking & Medication assistance


• Appointment scheduling & medical guidance

Healthcare Chatbots End User Outlook

• Patients


• Healthcare providers


• Insurance companies

Healthcare Chatbots Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America